Are you Dr. Stocks?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 65 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
11937 Us Highway 271
Tyler, TX 75708Phone+1 903-877-7916Fax+1 903-877-5838- Is this information wrong?
Summary
- Dr. James Stocks, MD is a pulmonologist in Tyler, Texas. He is currently licensed to practice medicine in Texas, New Mexico, and Pennsylvania. He is affiliated with UT Health North Campus Tyler and UT Health Tyler.
Education & Training
UPMC Medical EducationFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1985- UPMC Medical EducationResidency, Internal Medicine, 1979 - 1982
University of Texas Southwestern Medical SchoolClass of 1979
Certifications & Licensure
PA State Medical License 1981 - 2024
TX State Medical License 1979 - 2024
NM State Medical License 2019 - 2022
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency Start of enrollment: 2010 Nov 01
- Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subjects With Pulmonary Emphysema Due to Alpha1 Antitrypsin Deficiency (AATD) Start of enrollment: 2013 Nov 01
- Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation" Start of enrollment: 2014 Apr 01
Publications & Presentations
PubMed
- 2 citationsA 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacy.Jerome O. Cantor, Shuren Ma, Xingjian Liu, Michael Campos, C Strange, James M. Stocks, Megan S. Devine, Sherif G. El Bayadi, Randolph J. Lipchik, Robert A. Sandhaus, G...> ;Respiratory Medicine. 2021 Jun 1
- 29 citationsAnalysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.Nishant Gupta, Hye-Seung Lee, Lisa R. Young, C Strange, Joel Moss, Lianne G. Singer, Koh Nakata, Alan F. Barker, Jeffrey T. Chapman, Mark L. Brantly, James M. Stocks, ...> ;The European Respiratory Journal. 2019 Apr 1
- 4 citationsQuantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiency.Michael A. Tortorici, James A. Rogers, Oliver Vit, Martin Bexon, Robert A. Sandhaus, Jonathan Burdon, Joanna Chorostowska-Wynimko, Philip J. Thompson, James M. Stocks,...> ;British Journal of Clinical Pharmacology. 2017 Nov 1
- Join now to see all
Hospital Affiliations
- UT Health TylerTyler, Texas
- UT Health North Campus TylerTyler, Texas
